United Kingdom
Argentina 
Australia 
Austria 
Brazil 
Canada 
Germany 
Ireland 
Italy 
Malaysia 
Mexico 
New Zealand 
Poland 
South Africa 
United States Pfizer
The biggest-selling drugs of 2023
Move over Comirnaty: Keytruda takes top spot as its indications broaden and demand for Covid vaccines recedes.
Pfizer, one of the leading pharmaceutical companies, has witnessed a significant shift in its best-selling drugs in 2023. While Comirnaty, the Covid-19 vaccine, had been dominating the market, it has now been surpassed by Keytruda. As the indications for Keytruda broaden and the demand for Covid vaccines recedes, Pfizer has seen a remarkable rise in the popularity and sales of this immunotherapy drug.
Keytruda, also known as pembrolizumab, is an anti-PD-1 therapy used in the treatment of various types of cancer. Its mechanism of action involves boosting the body's immune response to fight cancer cells. With its expanding indications, Keytruda has become a game-changer in the field of oncology. The drug has shown remarkable efficacy in treating advanced melanoma, lung cancer, and other malignancies.
Pfizer's success with Keytruda highlights the ever-evolving landscape of the pharmaceutical industry. As the demand for Covid vaccines decreases, companies like Pfizer are adapting to the changing needs of patients and healthcare providers. The rise of Keytruda as the top-selling drug showcases the importance of innovation and the continuous development of groundbreaking therapies to address unmet medical needs.
```htmlPfizer
The biggest-selling drugs of 2023
Move over Comirnaty: Keytruda takes top spot as its indications broaden and demand for Covid vaccines recedes.
Pfizer, one of the leading pharmaceutical companies, has witnessed a significant shift in its best-selling drugs in 2023. While Comirnaty, the Covid-19 vaccine, had been dominating the market, it has now been surpassed by Keytruda. As the indications for Keytruda broaden and the demand for Covid vaccines recedes, Pfizer has seen a remarkable rise in the popularity and sales of this immunotherapy drug.
Keytruda, also known as pembrolizumab, is an anti-PD-1 therapy used in the treatment of various types of cancer. Its mechanism of action involves boosting the body's immune response to fight cancer cells. With its expanding indications, Keytruda has become a game-changer in the field of oncology. The drug has shown remarkable efficacy in treating advanced melanoma, lung cancer, and other malignancies.
Pfizer's success with Keytruda highlights the ever-evolving landscape of the pharmaceutical industry. As the demand for Covid vaccines decreases, companies like Pfizer are adapting to the changing needs of patients and healthcare providers. The rise of Keytruda as the top-selling drug showcases the importance of innovation and the continuous development of groundbreaking therapies to address unmet medical needs.
```
